Michael MBA - Novo Resources Ex CEO
NVOOFDelisted Stock | USD 0.01 0.00 0.00% |
Insider
Michael MBA is Ex CEO of Novo Resources Corp
Phone | 604-562-4854 |
Web | https://www.novoresources.com |
Novo Resources Management Efficiency
The company has return on total asset (ROA) of (0.1062) % which means that it has lost $0.1062 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4899) %, meaning that it generated substantial loss on money invested by shareholders. Novo Resources' management efficiency ratios could be used to measure how well Novo Resources manages its routine affairs as well as how well it operates its assets and liabilities.Novo Resources Corp has accumulated 37.38 M in total debt with debt to equity ratio (D/E) of 0.25, which may suggest the company is not taking enough advantage from borrowing. Novo Resources Corp has a current ratio of 3.17, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Novo Resources until it has trouble settling it off, either with new capital or with free cash flow. So, Novo Resources' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Novo Resources Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Novo to invest in growth at high rates of return. When we think about Novo Resources' use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Trym Sjlie | SFL Corporation | N/A | |
William MD | Viemed Healthcare | 66 | |
James OShaughnessy | SFL Corporation | 57 | |
Nicole Priest | Merit Medical Systems | N/A | |
Stephen CFA | Western Acquisition Ventures | 39 | |
Belinda Hyde | Waters | 53 | |
Jiang Wei | Waters | N/A | |
John Knorpp | Merit Medical Systems | N/A | |
CPA Parra | Merit Medical Systems | 46 | |
Jeremy Trahan | Viemed Healthcare | 54 | |
Kevin Kempskie | Waters | N/A | |
Jason Treft | Merit Medical Systems | N/A | |
Michael Freeman | Viemed Healthcare | N/A | |
Trae Fitzgerald | Viemed Healthcare | 36 | |
Joseph Pierce | Merit Medical Systems | N/A | |
John Ballbach | Waters | 60 | |
William Lischak | Western Acquisition Ventures | 66 | |
Dan Welch | Waters | 58 | |
Jannicke Eilertsen | SFL Corporation | N/A | |
Keeley Aleman | Waters | 47 | |
Kathrine Fredriksen | SFL Corporation | 38 |
Management Performance
Return On Equity | -0.49 | |||
Return On Asset | -0.11 |
Novo Resources Corp Leadership Team
Elected by the shareholders, the Novo Resources' board of directors comprises two types of representatives: Novo Resources inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novo. The board's role is to monitor Novo Resources' management team and ensure that shareholders' interests are well served. Novo Resources' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novo Resources' outside directors are responsible for providing unbiased perspectives on the board's policies.
Alwin Roij, Exploration Geologist | ||
Leonidas Karabelas, VP Communications | ||
Michael MBA, Ex CEO | ||
Ronan SaboWalsh, CFO Sec | ||
Karen Luca, Gen Exploration |
Novo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Novo Resources a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.49 | |||
Return On Asset | -0.11 | |||
Profit Margin | (1.28) % | |||
Operating Margin | (0.61) % | |||
Price To Earning | 2.30 X | |||
Revenue | 112.24 M | |||
EBITDA | 43.34 M | |||
Net Income | (704 K) | |||
Cash And Equivalents | 21.94 M | |||
Cash Per Share | 0.09 X |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Novo Pink Sheet
If you are still planning to invest in Novo Resources Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Resources' history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stocks Directory Find actively traded stocks across global markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |